Growing pragmatism about the safety of stocks in the chemical sector by top investment advisors stems from the fact that there is an increased demand in export markets and growth in specific Pharmaceutical segments
The acquisition of Chryso perfectly fits within Saint-Gobain’s strategic vision of worldwide leadership for sustainable construction
The deal is expected to close in June 2021
The company has reported total income of Rs.826.40 crores for FY 2020-21
The company has reported total income of Rs.760.74 crores for FY 2020-21
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
The company plans to enter the EU markets in FY22
KPIC in Korea will benefit from technology's low operating, maintenance and investment costs
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
The unadjusted data show a 1.0% increase in May following a 0.9% gain in April.
Huntsman expects the offering to close on May 26, 2021, subject to customary closing conditions.
The company has an authorized capital of 10,000,000 shares of Indonesia Rupiah 1,000 per share aggregating to Ten billion Rupiah
The new plant will be dedicated to the manufacturing of a broad range of waterproofing and construction chemicals solutions, as well as 3D printing solutions to support the Group’s pioneer positioning in this new market segment
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
The company reported total income of Rs.1475.59 crores during the 12 months period ended March 31, 2021
PPG expects that all conditions to the completion of the tender offer will be fulfilled at the tender offer expiration date of June 4, 2021.
The company launched and expanded sales of acrylic rubber and non-phthalate allyl resins
Q4 FY21 revenues reached Rs. 1,469 crore, up by 39% Y-o-Y whereas Profit After Tax at Rs. 290 crore, rose 68% on a Y-o-Y basis
Company is investing 117 million euros to strengthen its global leadership in the manufacture of LAB, which will enable it to increase production to meet the growing demand generated by the COVID-19 pandemic
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
